| Normal-GLI | Obstructive-GLI | Restrictive/Non-specific-GLI | Mixed-GLI | |
|---|---|---|---|---|
| Normal | 278 | 0 | 5 | 0 |
| Obstructive | 79 | 67 | 0 | 0 |
| Restrictive/Non-specific | 6 | 0 | 24 | 0 |
| Mixed | 1 | 0 | 3 | 5 |
| Normal-GLI | Obstructive-GLI | Restrictive/Non-specific-GLI | Mixed-GLI | |
|---|---|---|---|---|
| Normal | 126 | 0 | 0 | 0 |
| Obstructive | 40 | 42 | 0 | 0 |
| Restrictive/Non-specific | 6 | 0 | 14 | 0 |
| Mixed | 1 | 0 | 1 | 4 |
| Normal-GLI | Obstructive-GLI | Restrictive/Non-specific-GLI | Mixed-GLI | |
|---|---|---|---|---|
| Normal | 152 | 0 | 5 | 0 |
| Obstructive | 39 | 25 | 0 | 0 |
| Restrictive/Non-specific | 0 | 0 | 10 | 0 |
| Mixed | 0 | 0 | 2 | 1 |
##
## Normal-GLI Mild-GLI Moderate-GLI Severe-GLI
## Normal 414 8 0 0
## Mild 8 24 0 0
## Moderate 0 0 10 0
## Severe 0 0 2 2
##
## Normal-GLI Mild-GLI Moderate-GLI Severe-GLI
## Normal 362 1 0 0
## Mild 25 42 0 0
## Moderate 0 13 17 0
## Severe 0 0 4 4
## Stratified by sexo
## Female Male p test
## n 191 277
## Age (years) (median [IQR]) 8.93 [7.76, 10.72] 9.20 [7.43, 10.95] 0.493 nonnorm
## Height (cm) (median [IQR]) 133.00 [123.00, 145.00] 134.00 [125.50, 144.00] 0.447 nonnorm
## Stratified by sexo
## Female Male p test
## n 191 277
## CVF (median [IQR]) 1.88 [1.54, 2.28] 2.09 [1.68, 2.40] 0.004 nonnorm
## VEF1 (median [IQR]) 1.66 [1.35, 1.92] 1.69 [1.36, 1.99] 0.197 nonnorm
## VEF1/CVF (median [IQR]) 0.88 [0.83, 0.91] 0.84 [0.78, 0.90] <0.001 nonnorm
## FEF25-75% (median [IQR]) 1.87 [1.48, 2.37] 1.73 [1.38, 2.33] 0.111 nonnorm
## FEF25-75%/CVF (median [IQR]) 1.03 [0.82, 1.22] 0.86 [0.68, 1.11] <0.001 nonnorm
## Stratified by sexo
## Female Male p test
## n 191 277
## CVF_pos (median [IQR]) 1.89 [1.58, 2.30] 2.13 [1.73, 2.48] <0.001 nonnorm
## VEF1_pos (median [IQR]) 1.71 [1.44, 2.04] 1.87 [1.48, 2.16] 0.018 nonnorm
## VEF1/CVF_pos (median [IQR]) 0.91 [0.87, 0.93] 0.87 [0.84, 0.91] <0.001 nonnorm
## FEF25-75%_pos (median [IQR]) 2.29 [1.88, 2.72] 2.21 [1.82, 2.76] 0.403 nonnorm
## FEF25-75%/CVF_pos (median [IQR]) 1.20 [1.02, 1.40] 1.05 [0.88, 1.22] <0.001 nonnorm
## Stratified by sexo
## Female Male p test
## n 191 277
## cvf_z (median [IQR]) -0.42 [-0.93, 0.22] -0.30 [-0.99, 0.27] 0.604 nonnorm
## vef1_z (median [IQR]) -0.72 [-1.48, -0.10] -0.84 [-1.61, -0.18] 0.316 nonnorm
## vef1cvf_z (median [IQR]) -0.73 [-1.70, 0.02] -1.01 [-2.12, 0.10] 0.146 nonnorm
## fef2575_z (median [IQR]) -0.97 [-1.91, -0.04] -1.21 [-2.07, -0.15] 0.325 nonnorm
## fef2575cvf_z (median [IQR]) -0.51 [-1.34, 0.05] -0.79 [-1.63, 0.15] 0.211 nonnorm
##
## Overall
## n 468
## Var %CVF Basal (mean (SD)) 3.01 (5.65)
## Var absoluta CVF (mean (SD)) 51.61 (98.14)
## Var %CVF previsto (mean (SD)) 2.68 (5.14)
## Var %VEF1 Basal (mean (SD)) 7.54 (8.08)
## Var absoluta VEF1 (mean (SD)) 117.49 (115.92)
## Var %VEF1 previsto (mean (SD)) 6.33 (6.22)
| Female (N=191) |
Male (N=277) |
Overall (N=468) |
|
|---|---|---|---|
| Var %CVF Basal | |||
| Mean (SD) | 2.39 (5.49) | 3.45 (5.72) | 3.01 (5.65) |
| Median [Min, Max] | 1.76 [-17.3, 22.6] | 2.21 [-17.2, 40.4] | 2.01 [-17.3, 40.4] |
| Missing | 0 (0%) | 2 (0.7%) | 2 (0.4%) |
| Var absoluta CVF | |||
| Mean (SD) | 35.9 (92.4) | 62.5 (101) | 51.6 (98.1) |
| Median [Min, Max] | 30.0 [-390, 440] | 50.0 [-320, 460] | 40.0 [-390, 460] |
| Missing | 0 (0%) | 2 (0.7%) | 2 (0.4%) |
| Var %CVF previsto | |||
| Mean (SD) | 2.04 (4.90) | 3.12 (5.26) | 2.68 (5.14) |
| Median [Min, Max] | 1.73 [-20.5, 18.3] | 2.26 [-20.8, 31.7] | 1.92 [-20.8, 31.7] |
| Missing | 0 (0%) | 2 (0.7%) | 2 (0.4%) |
| Overall (N=468) |
|
|---|---|
| Var %VEF1 Basal | |
| Mean (SD) | 7.54 (8.08) |
| Median [Min, Max] | 6.25 [-15.6, 62.5] |
| Missing | 2 (0.4%) |
| Var absoluta VEF1 | |
| Mean (SD) | 117 (116) |
| Median [Min, Max] | 100 [-280, 850] |
| Missing | 2 (0.4%) |
| Var %VEF1 previsto | |
| Mean (SD) | 6.33 (6.22) |
| Median [Min, Max] | 5.64 [-13.2, 35.9] |
| Missing | 2 (0.4%) |
## Stratified by sexo
## Female Male p test
## n 191 277
## Var %CVF Basal (median [IQR]) 1.76 [-0.44, 4.85] 2.21 [0.00, 6.05] 0.050 nonnorm
## Var absoluta CVF (median [IQR]) 30.00 [-10.00, 85.00] 50.00 [0.00, 115.00] 0.011 nonnorm
## Var %CVF previsto (median [IQR]) 1.73 [-0.47, 4.61] 2.26 [0.00, 5.44] 0.043 nonnorm
## Var %VEF1 Basal (median [IQR]) 4.86 [1.49, 9.18] 6.91 [3.18, 11.70] 0.001 nonnorm
## Var absoluta VEF1 (median [IQR]) 80.00 [25.00, 140.00] 120.00 [60.00, 190.00] <0.001 nonnorm
## Var %VEF1 previsto (median [IQR]) 4.46 [1.32, 8.19] 6.25 [2.87, 9.94] 0.001 nonnorm
## Stratified by sexo
## Female Male p test
## n 191 277
## Var %CVF Basal (mean (SD)) 2.39 (5.49) 3.45 (5.72) 0.046
## Var absoluta CVF (mean (SD)) 35.86 (92.42) 62.55 (100.65) 0.004
## Var %CVF previsto (mean (SD)) 2.04 (4.90) 3.12 (5.26) 0.025
## Var %VEF1 Basal (mean (SD)) 6.16 (7.11) 8.50 (8.58) 0.002
## Var absoluta VEF1 (mean (SD)) 91.47 (99.90) 135.57 (122.82) <0.001
## Var %VEF1 previsto (mean (SD)) 5.22 (5.55) 7.10 (6.55) 0.001
| Overall (N=468) |
|
|---|---|
| Resposta >10% do CVF Basal | |
| No | 417 (89.1%) |
| Yes | 49 (10.5%) |
| Missing | 2 (0.4%) |
| Resposta >10% do CVF Previsto | |
| No | 427 (91.2%) |
| Yes | 39 (8.3%) |
| Missing | 2 (0.4%) |
| Resposta >12% do CVF Basal | |
| No | 436 (93.2%) |
| Yes | 30 (6.4%) |
| Missing | 2 (0.4%) |
| Resposta >150mL do CVF Basal | |
| No | 402 (85.9%) |
| Yes | 64 (13.7%) |
| Missing | 2 (0.4%) |
| Resposta >200mL do CVF Basal | |
| No | 434 (92.7%) |
| Yes | 32 (6.8%) |
| Missing | 2 (0.4%) |
| Overall (N=468) |
|
|---|---|
| Resposta >10% do vef1 Basal | |
| No | 331 (70.7%) |
| Yes | 135 (28.8%) |
| Missing | 2 (0.4%) |
| Resposta >10% do vef1 Previsto | |
| No | 368 (78.6%) |
| Yes | 98 (20.9%) |
| Missing | 2 (0.4%) |
| Resposta >12% do vef1 Basal | |
| No | 372 (79.5%) |
| Yes | 94 (20.1%) |
| Missing | 2 (0.4%) |
| Resposta >150mL do vef1 Basal | |
| No | 323 (69.0%) |
| Yes | 143 (30.6%) |
| Missing | 2 (0.4%) |
| Resposta >200mL do vef1 Basal | |
| No | 380 (81.2%) |
| Yes | 86 (18.4%) |
| Missing | 2 (0.4%) |
| Overall (N=468) |
|
|---|---|
| CVF dentro dos limites da normalidade | |
| No | 46 (9.8%) |
| Yes | 422 (90.2%) |
| VEF1 dentro dos limites da normalidade | |
| No | 105 (22.4%) |
| Yes | 363 (77.6%) |
| VEF1/CVF dentro dos limites da normalidade | |
| No | 155 (33.1%) |
| Yes | 313 (66.9%) |
| Overall (N=468) |
|
|---|---|
| CVF dentro dos limites da normalidade | |
| No | 29 (6.2%) |
| Yes | 437 (93.4%) |
| Missing | 2 (0.4%) |
| VEF1 dentro dos limites da normalidade | |
| No | 50 (10.7%) |
| Yes | 416 (88.9%) |
| Missing | 2 (0.4%) |
| VEF1/CVF dentro dos limites da normalidade | |
| No | 62 (13.2%) |
| Yes | 404 (86.3%) |
| Missing | 2 (0.4%) |
| Overall (N=468) |
|
|---|---|
| Classificação da Espirometria PRÉ-BD | |
| Normal | 283 (60.5%) |
| Obstructive | 146 (31.2%) |
| Restrictive/Non-specific | 30 (6.4%) |
| Mixed | 9 (1.9%) |
| Overall (N=468) |
|
|---|---|
| Classificação da Espirometria PÓS-BD | |
| Normal | 388 (82.9%) |
| Obstructive | 57 (12.2%) |
| Restrictive/Non-specific | 18 (3.8%) |
| Mixed | 5 (1.1%) |
| Overall (N=468) |
|
|---|---|
| CVF: Classificacao de Severidade | |
| Normal | 422 (90.2%) |
| Mild | 32 (6.8%) |
| Moderate | 10 (2.1%) |
| Severe | 4 (0.9%) |
| Overall (N=468) |
|
|---|---|
| VEF1: Classificacao de Severidade | |
| Normal | 363 (77.6%) |
| Mild | 67 (14.3%) |
| Moderate | 30 (6.4%) |
| Severe | 8 (1.7%) |
| Normal (N=283) |
Obstructive (N=146) |
Restrictive/Non-specific (N=30) |
Mixed (N=9) |
Overall (N=468) |
|
|---|---|---|---|---|---|
| Resposta >10% do CVF Basal | |||||
| No | 261 (92.2%) | 129 (88.4%) | 23 (76.7%) | 4 (44.4%) | 417 (89.1%) |
| Yes | 21 (7.4%) | 17 (11.6%) | 6 (20.0%) | 5 (55.6%) | 49 (10.5%) |
| Missing | 1 (0.4%) | 0 (0%) | 1 (3.3%) | 0 (0%) | 2 (0.4%) |
| Resposta >10% do CVF Previsto | |||||
| No | 264 (93.3%) | 129 (88.4%) | 26 (86.7%) | 8 (88.9%) | 427 (91.2%) |
| Yes | 18 (6.4%) | 17 (11.6%) | 3 (10.0%) | 1 (11.1%) | 39 (8.3%) |
| Missing | 1 (0.4%) | 0 (0%) | 1 (3.3%) | 0 (0%) | 2 (0.4%) |
| Resposta >150mL do CVF Basal | |||||
| No | 249 (88.0%) | 122 (83.6%) | 25 (83.3%) | 6 (66.7%) | 402 (85.9%) |
| Yes | 33 (11.7%) | 24 (16.4%) | 4 (13.3%) | 3 (33.3%) | 64 (13.7%) |
| Missing | 1 (0.4%) | 0 (0%) | 1 (3.3%) | 0 (0%) | 2 (0.4%) |
| Resposta >200mL do CVF Basal | |||||
| No | 270 (95.4%) | 132 (90.4%) | 26 (86.7%) | 6 (66.7%) | 434 (92.7%) |
| Yes | 12 (4.2%) | 14 (9.6%) | 3 (10.0%) | 3 (33.3%) | 32 (6.8%) |
| Missing | 1 (0.4%) | 0 (0%) | 1 (3.3%) | 0 (0%) | 2 (0.4%) |
| Normal (N=283) |
Obstructive (N=146) |
Restrictive/Non-specific (N=30) |
Mixed (N=9) |
Overall (N=468) |
|
|---|---|---|---|---|---|
| Var %CVF Basal | |||||
| Mean (SD) | 2.82 (5.13) | 2.67 (5.87) | 4.74 (7.63) | 9.18 (6.66) | 3.01 (5.65) |
| Median [Min, Max] | 2.02 [-9.63, 40.4] | 1.81 [-17.3, 19.2] | 4.13 [-7.58, 22.6] | 11.7 [1.40, 20.4] | 2.01 [-17.3, 40.4] |
| Missing | 1 (0.4%) | 0 (0%) | 1 (3.3%) | 0 (0%) | 2 (0.4%) |
| Var absoluta CVF | |||||
| Mean (SD) | 49.7 (89.6) | 48.3 (110) | 65.5 (113) | 121 (96.1) | 51.6 (98.1) |
| Median [Min, Max] | 40.0 [-220, 460] | 35.0 [-390, 360] | 50.0 [-90.0, 440] | 100 [20.0, 280] | 40.0 [-390, 460] |
| Missing | 1 (0.4%) | 0 (0%) | 1 (3.3%) | 0 (0%) | 2 (0.4%) |
| Var %CVF previsto | |||||
| Mean (SD) | 2.61 (4.67) | 2.52 (5.93) | 3.13 (5.21) | 6.03 (4.90) | 2.68 (5.14) |
| Median [Min, Max] | 1.91 [-10.5, 31.7] | 1.80 [-20.8, 19.4] | 3.16 [-5.75, 16.3] | 5.34 [1.10, 15.7] | 1.92 [-20.8, 31.7] |
| Missing | 1 (0.4%) | 0 (0%) | 1 (3.3%) | 0 (0%) | 2 (0.4%) |
| Normal (N=283) |
Obstructive (N=146) |
Restrictive/Non-specific (N=30) |
Mixed (N=9) |
Overall (N=468) |
|
|---|---|---|---|---|---|
| Resposta >10% do vef1 Basal | |||||
| No | 239 (84.5%) | 68 (46.6%) | 21 (70.0%) | 3 (33.3%) | 331 (70.7%) |
| Yes | 43 (15.2%) | 78 (53.4%) | 8 (26.7%) | 6 (66.7%) | 135 (28.8%) |
| Missing | 1 (0.4%) | 0 (0%) | 1 (3.3%) | 0 (0%) | 2 (0.4%) |
| Resposta >10% do vef1 Previsto | |||||
| No | 246 (86.9%) | 90 (61.6%) | 27 (90.0%) | 5 (55.6%) | 368 (78.6%) |
| Yes | 36 (12.7%) | 56 (38.4%) | 2 (6.7%) | 4 (44.4%) | 98 (20.9%) |
| Missing | 1 (0.4%) | 0 (0%) | 1 (3.3%) | 0 (0%) | 2 (0.4%) |
| Resposta >150mL do vef1 Basal | |||||
| No | 232 (82.0%) | 62 (42.5%) | 25 (83.3%) | 4 (44.4%) | 323 (69.0%) |
| Yes | 50 (17.7%) | 84 (57.5%) | 4 (13.3%) | 5 (55.6%) | 143 (30.6%) |
| Missing | 1 (0.4%) | 0 (0%) | 1 (3.3%) | 0 (0%) | 2 (0.4%) |
| Resposta >200mL do vef1 Basal | |||||
| No | 253 (89.4%) | 95 (65.1%) | 26 (86.7%) | 6 (66.7%) | 380 (81.2%) |
| Yes | 29 (10.2%) | 51 (34.9%) | 3 (10.0%) | 3 (33.3%) | 86 (18.4%) |
| Missing | 1 (0.4%) | 0 (0%) | 1 (3.3%) | 0 (0%) | 2 (0.4%) |
| Normal (N=283) |
Obstructive (N=146) |
Restrictive/Non-specific (N=30) |
Mixed (N=9) |
Overall (N=468) |
|
|---|---|---|---|---|---|
| Var %VEF1 Basal | |||||
| Mean (SD) | 4.99 (5.83) | 12.1 (8.82) | 6.36 (9.76) | 16.8 (12.2) | 7.54 (8.08) |
| Median [Min, Max] | 4.00 [-13.6, 39.8] | 10.7 [-5.04, 62.5] | 5.06 [-15.6, 35.8] | 18.8 [1.83, 33.3] | 6.25 [-15.6, 62.5] |
| Missing | 1 (0.4%) | 0 (0%) | 1 (3.3%) | 0 (0%) | 2 (0.4%) |
| Var absoluta VEF1 | |||||
| Mean (SD) | 86.1 (97.6) | 181 (121) | 90.0 (127) | 157 (111) | 117 (116) |
| Median [Min, Max] | 80.0 [-280, 580] | 165 [-60.0, 850] | 70.0 [-70.0, 580] | 170 [20.0, 300] | 100 [-280, 850] |
| Missing | 1 (0.4%) | 0 (0%) | 1 (3.3%) | 0 (0%) | 2 (0.4%) |
| Var %VEF1 previsto | |||||
| Mean (SD) | 4.56 (5.21) | 9.97 (6.45) | 4.50 (6.29) | 8.50 (5.79) | 6.33 (6.22) |
| Median [Min, Max] | 3.82 [-13.2, 33.9] | 9.08 [-4.54, 35.9] | 3.49 [-6.13, 24.0] | 8.98 [0.930, 16.8] | 5.64 [-13.2, 35.9] |
| Missing | 1 (0.4%) | 0 (0%) | 1 (3.3%) | 0 (0%) | 2 (0.4%) |
| Overall (N=468) |
|
|---|---|
| Normalizacao da Função Pulmonar | |
| Normal: No change | 280 (59.8%) |
| Normalization of lung function | 108 (23.1%) |
| Abnormal: No change | 77 (16.5%) |
| Normal before, Abnormal after BD | 3 (0.6%) |
| Normal (N=283) |
Obstructive (N=146) |
Restrictive/Non-specific (N=30) |
Mixed (N=9) |
Overall (N=468) |
|
|---|---|---|---|---|---|
| Normalizacao da Função Pulmonar | |||||
| Normal: No change | 280 (98.9%) | 0 (0%) | 0 (0%) | 0 (0%) | 280 (59.8%) |
| Normalization of lung function | 0 (0%) | 96 (65.8%) | 11 (36.7%) | 1 (11.1%) | 108 (23.1%) |
| Abnormal: No change | 0 (0%) | 50 (34.2%) | 19 (63.3%) | 8 (88.9%) | 77 (16.5%) |
| Normal before, Abnormal after BD | 3 (1.1%) | 0 (0%) | 0 (0%) | 0 (0%) | 3 (0.6%) |
## Stratified by sexo
## Female Male p test
## n 191 277
## FEF25-75%/CVF (median [IQR]) 1.03 [0.82, 1.22] 0.86 [0.68, 1.11] <0.001 nonnorm
## fef2575cvf_z (median [IQR]) -0.51 [-1.34, 0.05] -0.79 [-1.63, 0.15] 0.211 nonnorm
## FEF25-75%/CVF_pos (median [IQR]) 1.20 [1.02, 1.40] 1.05 [0.88, 1.22] <0.001 nonnorm
## fef2575cvf_z_pos (median [IQR]) -0.03 [-0.55, 0.49] -0.08 [-0.74, 0.54] 0.588 nonnorm
## delta_fef2575 (median [IQR]) 0.74 [0.35, 1.38] 0.88 [0.42, 1.49] 0.072 nonnorm
## delta_vef1 (median [IQR]) 0.35 [0.11, 0.64] 0.52 [0.24, 0.86] <0.001 nonnorm
## delta_cvf (median [IQR]) 0.12 [-0.03, 0.33] 0.16 [0.00, 0.43] 0.024 nonnorm
##
## Overall
## n 468
## FEF25-75%/CVF (median [IQR]) 0.94 [0.73, 1.15]
## fef2575cvf_z (median [IQR]) -0.69 [-1.52, 0.09]
## FEF25-75%/CVF_pos (median [IQR]) 1.11 [0.93, 1.31]
## fef2575cvf_z_pos (median [IQR]) -0.06 [-0.67, 0.53]
## delta_fef2575 (median [IQR]) 0.83 [0.41, 1.42]
## delta_vef1 (median [IQR]) 0.47 [0.19, 0.79]
## delta_cvf (median [IQR]) 0.14 [0.00, 0.39]
##
## Normal-GLI Obstructive-GLI Restrictive/Non-specific-GLI Mixed-GLI
## Normal 278 0 5 0
## Obstructive 79 67 0 0
## Restrictive/Non-specific 6 0 24 0
## Mixed 1 0 3 5
##
## Normal-GLI Mild-GLI Moderate-GLI Severe-GLI
## Normal 362 1 0 0
## Mild 25 42 0 0
## Moderate 0 13 17 0
## Severe 0 0 4 4
##
## Normal-GLI Mild-GLI Moderate-GLI Severe-GLI
## Normal 414 8 0 0
## Mild 8 24 0 0
## Moderate 0 0 10 0
## Severe 0 0 2 2